A “Method of Use” to Prevent Generic and Biosimilar Market Entry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A “Method of Use” to Prevent Generic and Biosimilar Market Entry

Published:2023-02-09 Issue:6 Volume:388 Page:483-485
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Tu S. Sean¹,Sarpatwari Ameet¹^ORCID

Affiliation:

1. From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (S.S.T., A.S.); and West Virginia University College of Law, Morgantown (S.S.T.).

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp2216020

Reference3 articles.

1. Biological patent thickets and delayed access to biosimilars, an American problem

2. Frequency of First Generic Drug Approvals With “Skinny Labels” in the United States

3. Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilars in Dermatology Review;Journal of Psoriasis and Psoriatic Arthritis;2023-11-03

2. Preserving Timely Generic Drug Competition with Legislation on “Skinny Labeling”;Clinical Pharmacology & Therapeutics;2023-10-24

3. Are Cancer Biosimilars Similar and Significant Enough to Deserve More Attention?;JAMA Network Open;2023-10-12

4. Changes in the Number of Continuation Patents on Drugs Approved by the FDA;JAMA;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP